Verition Fund Management’s Zimmer Biomet ZBH Stock Holding History

Verition Fund Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-60,203	Closed	-$5.41M	–	3678
2025 Q4	$5.41M	Sell	60,203 -16,237	-21%	-$1.54M	0.02%	818
2025 Q3	$7.53M	Buy	76,440 +48,805	+177%	+$4.84M	0.03%	742
2025 Q2	$2.52M	Sell	27,635 -127,097	-82%	-$12.3M	0.01%	1751
2025 Q1	$17.5M	Buy	154,732 +130,575	+541%	+$14M	0.08%	266
2024 Q4	$2.55M	Buy	24,157 +20,598	+579%	+$2.21M	0.01%	1396
2024 Q3	$384K	Sell	3,559 -95,314	-96%	-$10.4M	﹤0.01%	2487
2024 Q2	$10.7M	Buy	98,873 +68,420	+225%	+$8.07M	0.06%	322
2024 Q1	$4.02M	Sell	30,453 -11,471	-27%	-$1.43M	0.03%	808
2023 Q4	$5.1M	Buy	41,924 +18,475	+79%	+$2.06M	0.04%	438
2023 Q3	$2.63M	Buy	23,449 +20,365	+660%	+$2.59M	0.03%	674
2023 Q2	$449K	Sell	3,084 -2,817	-48%	-$383K	0.01%	1303
2023 Q1	$762K	Buy	+5,901	New	+$741K	0.01%	1049
2022 Q3	–	Sell	-5,782	Closed	-$607K	–	3240
2022 Q2	$607K	Buy	+5,782	New	+$686K	0.01%	1325
2022 Q1	–	Sell	-4,584	Closed	-$565K	–	3084
2021 Q4	$565K	Buy	+4,584	New	+$600K	﹤0.01%	1632
2021 Q3	–	Sell	-1,870	Closed	-$292K	–	2365
2021 Q2	$292K	Sell	1,870 -2,064	-52%	-$334K	﹤0.01%	1357
2021 Q1	$611K	Buy	3,934 +2,489	+172%	+$386K	0.01%	765
2020 Q4	$216K	Buy	+1,445	New	+$204K	﹤0.01%	940
2020 Q3	–	Sell	-13,208	Closed	-$1.53M	–	1415
2020 Q2	$1.53M	Buy	+13,208	New	+$1.52M	0.05%	287
2019 Q3	–	Sell	-20,904	Closed	-$2.39M	–	1375
2019 Q2	$2.39M	Buy	+20,904	New	+$2.45M	0.07%	210
2019 Q1	–	Sell	-2,139	Closed	-$215K	–	1350
2018 Q4	$215K	Sell	2,139 -1,111	-34%	-$125K	0.02%	720
2018 Q3	$415K	Sell	3,250 -574	-15%	-$68.2K	0.01%	915
2018 Q2	$414K	Sell	3,824 -19,406	-84%	-$2.11M	0.03%	759
2018 Q1	$2.46M	Buy	+23,230	New	+$2.7M	0.18%	111
2017 Q4	–	Sell	-18,594	Closed	-$2.11M	–	1290
2017 Q3	$2.11M	Sell	18,594 -6,950	-27%	-$802K	0.17%	106
2017 Q2	$3.18M	Sell	25,544 -615	-2%	-$72.9K	0.31%	54
2017 Q1	$3.1M	Buy	26,159 +3,452	+15%	+$391K	0.29%	48
2016 Q4	$2.27M	Sell	22,707 -2,668	-11%	-$286K	0.2%	95
2016 Q3	$3.2M	Sell	25,375 -8,532	-25%	-$1.05M	0.34%	45
2016 Q2	$3.96M	Sell	33,907 -30,859	-48%	-$3.49M	0.51%	29
2016 Q1	$6.71M	Sell	64,766 -2,033	-3%	-$197K	1.08%	10
2015 Q4	$6.65M	Sell	66,799 -7,856	-11%	-$769K	1.27%	16
2015 Q3	$6.81M	Buy	74,655 +44,064	+144%	+$4.42M	1.77%	3
2015 Q2	$3.24M	Buy	30,591 +10,960	+56%	+$1.21M	0.57%	31
2015 Q1	$2.24M	Buy	19,631 +15,973	+437%	+$1.82M	0.26%	27
2014 Q4	$403K	Buy	+3,658	New	+$386K	0.09%	107
2014 Q3	–	Sell	-4,254	Closed	-$429K	–	900
2014 Q2	$429K	Buy	4,254 +1,895	+80%	+$185K	0.05%	299
2014 Q1	$217K	Sell	2,359 -349	-13%	-$32.2K	0.03%	373
2013 Q4	$245K	Buy	+2,708	New	+$234K	0.04%	322
2013 Q3	–	Sell	-8,716	Closed	-$634K	–	715
2013 Q2	$634K	Buy	+8,716	New	+$652K	0.12%	168

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Verition Fund Management's ZBH Position: Q1 2026 in Review

Verition Fund Management sold out of Zimmer Biomet (ZBH) in Q1 2026, closing a stake of 60,203 shares — an estimated $5.41M sold.

Verition Fund Management first reported a position in ZBH in Q2 2013 and held it in 39 quarters. The position peaked at $17.5M in Q1 2025. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

Verition Fund Management reported no remaining Zimmer Biomet position as of Q1 2026 after selling out during the quarter.
Verition Fund Management sold 60,203 Zimmer Biomet shares in Q1 2026, an estimated $5.41M.
Verition Fund Management first reported a position in Zimmer Biomet in Q2 2013 and held it in 39 quarters.
Verition Fund Management's Zimmer Biomet position peaked at $17.5M in Q1 2025.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.